Author:
Kim Hosoon,Yun Minhyuk,Kwon Kwang-il
Publisher
Springer Science and Business Media LLC
Subject
Organic Chemistry,Drug Discovery,Molecular Medicine
Reference7 articles.
1. Campbell, D. B., Adrianessens, P., Hopkins, Y. W., Gordon, B., and Williams, J. R. B., Pharmacokinetics and metabolism of gliclazide: G review. In Gliclazide and the Treatment of Diabetes, Keen H. London (ed).Academic Press and the Royal Society of Medicine, 71–82 (1980).
2. Davis, T. M. E., Daly, F., Walsh, J. P., Ilett, K. F., Beilby, J. P., Dusci, L. J., and Barrett, P. H. R., Pharmacokinetics and pharmacodynamics of gliclazide in Caucasians and Australian Aborigines with type 2 diabetes.Br. J. Clin. Pharmacol., 49, 223–230 (2000).
3. Glowka, F. K., Hermann, T. W., and Zabel, M., Bioavailablity of gliclazide from some formulation tablets.Int. J. Pharmceut., 172, 71–77 (1998).
4. Kimura, M., Kobayashi, K., Hata, M., Matsuoka, A., Kitamura, H., and Kimura, Y., Determination of gliclazide in human serum by high-performance liquid chromatography using an anion-exchange resin.J. Chromatogra., 183, 467–473 (1980).
5. Kobayashi, K., Kimura, M., Sakoguchi, T., Kitani, Y., and Hata, M., Influence of blood protein on biomedical analysis. III. Pharmacokinetics and protein binding of gliclazide.J. Pharmacodyn., 4, 436–442 (1981).
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献